[PDF][PDF] UNIVERZITET ODBRANE MINISTARSTVO ODBRANE REPUBLIKE SRBIJE MEDICINSKI FAKULTET VOJNOMEDICINSKE AKADEMIJE
JM Džudović - mfvma.mod.gov.rs
SAŽETAK UVOD: Antikoagulantna terapija direktnim oralnim antikoagulansima (DOAK) je
prema savremenim vodičima apsolutna preporuka za nastavak lečenje pacijenata sa …
prema savremenim vodičima apsolutna preporuka za nastavak lečenje pacijenata sa …
Oral anticoagulant therapy: clinical aspects
D Marisavljević - Srpski Arhiv za Celokupno Lekarstvo, 2007 - europepmc.org
Oral anticoagulants are effective in prevention and treatment of thromboembolism, but
despite refinements and standardization in their use, many problems remain for clinicians …
despite refinements and standardization in their use, many problems remain for clinicians …
Extended options of anticoagulant treatment in thromboembolism
D Karetová, J Bultas - Vnitrni Lekarstvi, 2014 - europepmc.org
Thromboembolic disease (TD) is a relatively common disease with acute risk of death and
potential long-term consequences in term of postthrombotic syndrome or chronic pulmonary …
potential long-term consequences in term of postthrombotic syndrome or chronic pulmonary …
[HTML][HTML] Direct oral anticoagulant drugs in the treatment of pulmonary thromboembolism
S Obradović, B Džudović, S Šalinger… - Galenika Medical …, 2022 - scindeks.ceon.rs
Introduction: Over the past 15 years, direct oral anticoagulant (DOAC) drugs have replaced
vitamin K antagonists in a number of indications requiring oral anticoagulant therapy …
vitamin K antagonists in a number of indications requiring oral anticoagulant therapy …
Разлике у активности фактора коагулационе каскаде и концентрацијама фибриногена и Д-димера, код пацијената са плућном тромбоемболијом на терапији …
J Џудовић - Универзитет одбране, 2023 - nardus.mpn.gov.rs
Терапија директним оралним антикоагулансима (ДОАК) је према савременим
водичима препоручена за лечење пацијената са плућном тромбоемболијом (ПТЕ) …
водичима препоручена за лечење пацијената са плућном тромбоемболијом (ПТЕ) …
[HTML][HTML] Direct oral anticoagulants and peripheral arterial disease
M Nešković, I Atanasijević, P Gajin - Galenika Medical Journal, 2022 - scindeks.ceon.rs
Peripheral arterial disease (PAD) is a disease of the arteries of the lower extremities and
represents a global health problem with an increasing prevalence rate. Evidence for the use …
represents a global health problem with an increasing prevalence rate. Evidence for the use …
„Poraz “antikoagulantne terapije u liječenju akutnoga ishemijskog moždanog udara?
Z Poljaković - Medicus, 2022 - hrcak.srce.hr
Sažetak Uloga antikoagulantne terapije u liječenju ishemijskoga moždanog udara
posljednjih se godina značajno mijenja. Iako je u primjeni u toj indikaciji već više od 50 …
posljednjih se godina značajno mijenja. Iako je u primjeni u toj indikaciji već više od 50 …
[HTML][HTML] Frequency of direct oral anticoagulants usage in acute pulmonary thromboembolism treatment in Turkey (TUPEDO)
E Tanrıverdi, N Tutar, A Şentürk, A Bahadır… - Balkan Medical …, 2022 - ncbi.nlm.nih.gov
Background: Direct oral anticoagulants (DOACs) have been used in acute pulmonary
thromboembolism as an alternative to warfarin due to drug interactions, narrow therapeutic …
thromboembolism as an alternative to warfarin due to drug interactions, narrow therapeutic …
Modern position of anticoagulants in acute pulmonary embolism: achievements, limitations, prospects
YV Terekhovskaya, VG Okorokov… - IP Pavlov Russian …, 2019 - journals.eco-vector.com
Pulmonary embolism (PE) is the third most common cardiovascular disease after myocardial
infarction and stroke, and one of the leading causes of death in Europe. Aim. Analysis of the …
infarction and stroke, and one of the leading causes of death in Europe. Aim. Analysis of the …
SEVEN ARGUMENTS AGAINST STARTING WARFARIN ON THE FIRST DAY OF PULMONARY THROMBOEMBOLISM
GP Koraćević, M Zdravković - Facta Universitatis, Series …, 2022 - casopisi.junis.ni.ac.rs
The aim is to analyze how the advances in pulmonary thromboembolism (PTE) may
influence its therapeutic protocol, focusing on the anti-vitamin K (AVK) start. Narrative review …
influence its therapeutic protocol, focusing on the anti-vitamin K (AVK) start. Narrative review …